Dr. Kathleen Sullivan of the Children's Hospital of Philadelphia provides an overview of here study on biomarkers for kidney disease in children and teens with lupus.
The Lupus Nephritis Trials Network (LNTN) is a worldwide organization that brings researchers together with the shared goal of improving outcomes for patients with lupus nephritis.
Dr. Stacy P. Ardoin's research will help determine whether levels of microRNA in the urine can indicate lupus nephritis-related disease activity and damage in the kidneys of children with lupus.
The Lupus Foundation of America Corporate Advisory Council provides industry perspective helping identify and address barriers to lupus drug development.
LFA-REAL is a two part system, based on a series of simple questions and observations, to determine a treatment’s impact on the patient’s health and daily life.
Jennifer Mall, M.P.H. discusses her research project as part of her Gina Finzi Fellowship experience during the summer of 2014.
Dr. Gary Gilkeson discusses the role of adult stem cells in the immune system and how they can be used to manage lupus.
More than 250 lupus activists from 31 states joined the fight for more lupus research funding.